A citation-based method for searching scientific literature

Chikashi Watase, Sho Shiino, Tatsunori Shimoi, Emi Noguchi, Tomoya Kaneda, Yusuke Yamamoto, Kan Yonemori, Shin Takayama, Akihiko Suto. Cancers (Basel) 2021
Times Cited: 11







List of co-cited articles
57 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Treatment strategies for breast cancer brain metastases.
Caroline Bailleux, Lauriane Eberst, Thomas Bachelot. Br J Cancer 2021
29
45

Management of brain metastases according to molecular subtypes.
Riccardo Soffietti, Manmeet Ahluwalia, Nancy Lin, Roberta Rudà. Nat Rev Neurol 2020
40
36

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Eric L Chang, Jeffrey S Wefel, Kenneth R Hess, Pamela K Allen, Frederick F Lang, David G Kornguth, Rebecca B Arbuckle, J Michael Swint, Almon S Shiu, Moshe H Maor,[...]. Lancet Oncol 2009
36

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.
Paul D Brown, Kurt Jaeckle, Karla V Ballman, Elana Farace, Jane H Cerhan, S Keith Anderson, Xiomara W Carrero, Fred G Barker, Richard Deming, Stuart H Burri,[...]. JAMA 2016
779
36

Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.
Jill S Barnholtz-Sloan, Andrew E Sloan, Faith G Davis, Fawn D Vigneau, Ping Lai, Raymond E Sawaya. J Clin Oncol 2004
974
36

Breast cancer brain metastases: the last frontier.
José Pablo Leone, Bernardo Amadeo Leone. Exp Hematol Oncol 2015
77
36

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study.
Thomas Bachelot, Gilles Romieu, Mario Campone, Véronique Diéras, Claire Cropet, Florence Dalenc, Marta Jimenez, Emilie Le Rhun, Jean-Yves Pierga, Anthony Gonçalves,[...]. Lancet Oncol 2013
426
27

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
Rashmi K Murthy, Sherene Loi, Alicia Okines, Elisavet Paplomata, Erika Hamilton, Sara A Hurvitz, Nancy U Lin, Virginia Borges, Vandana Abramson, Carey Anders,[...]. N Engl J Med 2020
400
27

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.
Nancy U Lin, Virginia Borges, Carey Anders, Rashmi K Murthy, Elisavet Paplomata, Erika Hamilton, Sara Hurvitz, Sherene Loi, Alicia Okines, Vandana Abramson,[...]. J Clin Oncol 2020
156
27


Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
Sandra M Swain, José Baselga, Sung-Bae Kim, Jungsil Ro, Vladimir Semiglazov, Mario Campone, Eva Ciruelos, Jean-Marc Ferrero, Andreas Schneeweiss, Sarah Heeson,[...]. N Engl J Med 2015
27

Brain metastases.
Achal Singh Achrol, Robert C Rennert, Carey Anders, Riccardo Soffietti, Manmeet S Ahluwalia, Lakshmi Nayak, Solange Peters, Nils D Arvold, Griffith R Harsh, Patricia S Steeg,[...]. Nat Rev Dis Primers 2019
272
27

Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype.
Nils D Arvold, Kevin S Oh, Andrzej Niemierko, Alphonse G Taghian, Nancy U Lin, Rita F Abi-Raad, Meera Sreedhara, Jay R Harris, Brian M Alexander. Breast Cancer Res Treat 2012
77
27

Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis.
Naoki Niikura, Naoki Hayashi, Norikazu Masuda, Seiki Takashima, Rikiya Nakamura, Ken-ichi Watanabe, Chizuko Kanbayashi, Mayumi Ishida, Yasuo Hozumi, Michiko Tsuneizumi,[...]. Breast Cancer Res Treat 2014
87
27

Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study.
Masaaki Yamamoto, Toru Serizawa, Takashi Shuto, Atsuya Akabane, Yoshinori Higuchi, Jun Kawagishi, Kazuhiro Yamanaka, Yasunori Sato, Hidefumi Jokura, Shoji Yomo,[...]. Lancet Oncol 2014
740
27

Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs.
Sara A Hurvitz, Joyce O'Shaughnessy, Ginny Mason, Denise A Yardley, Mohammad Jahanzeb, Adam Brufsky, Hope S Rugo, Sandra M Swain, Peter A Kaufman, Debu Tripathy,[...]. Clin Cancer Res 2019
32
18

Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.
Marc C Chamberlain, Christina S Baik, Vijayakrishna K Gadi, Shailender Bhatia, Laura Q M Chow. Neuro Oncol 2017
113
18

Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.
Shireen Parsai, Jacob A Miller, Aditya Juloori, Samuel T Chao, Rupesh Kotecha, Alireza M Mohammadi, Manmeet S Ahluwalia, Erin S Murphy, Gene H Barnett, Michael A Vogelbaum,[...]. J Neurosurg 2019
29
18

Response assessment criteria for brain metastases: proposal from the RANO group.
Nancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, Igor J Barani, Daniel P Barboriak, Brigitta G Baumert, Martin Bendszus, Paul D Brown, D Ross Camidge, Susan M Chang,[...]. Lancet Oncol 2015
430
18


The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis.
Fausto Petrelli, Michele Ghidini, Veronica Lonati, Gianluca Tomasello, Karen Borgonovo, Mara Ghilardi, Mary Cabiddu, Sandro Barni. Eur J Cancer 2017
59
18

Leptomeningeal carcinomatosis in patients with breast cancer.
Maria Alice Franzoi, Gabriel N Hortobagyi. Crit Rev Oncol Hematol 2019
43
18

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial.
Ahmad Awada, Ramon Colomer, Kenichi Inoue, Igor Bondarenko, Rajendra A Badwe, Georgia Demetriou, Soo-Chin Lee, Ajay O Mehta, Sung-Bae Kim, Thomas Bachelot,[...]. JAMA Oncol 2016
157
18

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.
Rachel A Freedman, Rebecca S Gelman, Carey K Anders, Michelle E Melisko, Heather A Parsons, Anne M Cropp, Kelly Silvestri, Christine M Cotter, Kathryn P Componeschi, Juan M Marte,[...]. J Clin Oncol 2019
164
18

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.
Shanu Modi, Cristina Saura, Toshinari Yamashita, Yeon Hee Park, Sung-Bae Kim, Kenji Tamura, Fabrice Andre, Hiroji Iwata, Yoshinori Ito, Junji Tsurutani,[...]. N Engl J Med 2020
518
18

Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis.
Joseph M Kim, Jacob A Miller, Rupesh Kotecha, Samuel T Chao, Manmeet S Ahluwalia, David M Peereboom, Alireza M Mohammadi, Gene H Barnett, Erin S Murphy, Michael A Vogelbaum,[...]. Neuro Oncol 2019
27
18


Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4.
Priscilla K Stumpf, Diana M Cittelly, Tyler P Robin, Julie A Carlson, Kelly A Stuhr, Maria Jose Contreras-Zarate, Steven Lai, D Ryan Ormond, Chad G Rusthoven, Laurie E Gaspar,[...]. Clin Cancer Res 2019
21
18

Activity of T-DM1 in Her2-positive breast cancer brain metastases.
Rupert Bartsch, Anna S Berghoff, Ursula Vogl, Margaretha Rudas, Elisabeth Bergen, Peter Dubsky, Karin Dieckmann, Katja Pinker, Zsuzsanna Bago-Horvath, Arik Galid,[...]. Clin Exp Metastasis 2015
79
18

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204).
Hussein A Tawbi, Peter A Forsyth, F Stephen Hodi, Christopher D Lao, Stergios J Moschos, Omid Hamid, Michael B Atkins, Karl Lewis, Reena P Thomas, John A Glaspy,[...]. Neuro Oncol 2021
22
18

A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast Cancer.
Sara M Tolaney, Solmaz Sahebjam, Emilie Le Rhun, Thomas Bachelot, Peter Kabos, Ahmad Awada, Denise Yardley, Arlene Chan, Pierfranco Conte, Véronique Diéras,[...]. Clin Cancer Res 2020
39
18

Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.
Anita Mahajan, Salmaan Ahmed, Mary Frances McAleer, Jeffrey S Weinberg, Jing Li, Paul Brown, Stephen Settle, Sujit S Prabhu, Frederick F Lang, Nicholas Levine,[...]. Lancet Oncol 2017
309
18

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.
Georgina V Long, Victoria Atkinson, Serigne Lo, Shahneen Sandhu, Alexander D Guminski, Michael P Brown, James S Wilmott, Jarem Edwards, Maria Gonzalez, Richard A Scolyer,[...]. Lancet Oncol 2018
478
18

Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data.
Faith G Davis, Therese A Dolecek, Bridget J McCarthy, John L Villano. Neuro Oncol 2012
128
18

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.
R A Patchell, P A Tibbs, W F Regine, R J Dempsey, M Mohiuddin, R J Kryscio, W R Markesbery, K A Foon, B Young. JAMA 1998
18

What factors predict the response of larger brain metastases to radiosurgery?
Huai-che Yang, Hideyuki Kano, L Dade Lunsford, Ajay Niranjan, John C Flickinger, Douglas Kondziolka. Neurosurgery 2011
39
18

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.
Priscilla K Brastianos, Scott L Carter, Sandro Santagata, Daniel P Cahill, Amaro Taylor-Weiner, Robert T Jones, Eliezer M Van Allen, Michael S Lawrence, Peleg M Horowitz, Kristian Cibulskis,[...]. Cancer Discov 2015
549
18

Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.
Martin Kocher, Riccardo Soffietti, Ufuk Abacioglu, Salvador Villà, Francois Fauchon, Brigitta G Baumert, Laura Fariselli, Tzahala Tzuk-Shina, Rolf-Dieter Kortmann, Christian Carrie,[...]. J Clin Oncol 2011
18

A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
Riccardo Soffietti, Martin Kocher, Ufuk M Abacioglu, Salvador Villa, François Fauchon, Brigitta G Baumert, Laura Fariselli, Tzahala Tzuk-Shina, Rolf-Dieter Kortmann, Christian Carrie,[...]. J Clin Oncol 2013
422
18

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
Hussein A Tawbi, Peter A Forsyth, Alain Algazi, Omid Hamid, F Stephen Hodi, Stergios J Moschos, Nikhil I Khushalani, Karl Lewis, Christopher D Lao, Michael A Postow,[...]. N Engl J Med 2018
623
18

Subtypes of breast cancer show different spatial distributions of brain metastases.
Sunghyon Kyeong, Yoon Jin Cha, Sung Gwe Ahn, Sang Hyun Suh, Eun Ju Son, Sung Jun Ahn. PLoS One 2017
21
18

Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort.
Amélie Darlix, Guillaume Louvel, Julien Fraisse, William Jacot, Etienne Brain, Marc Debled, Marie Ange Mouret-Reynier, Anthony Goncalves, Florence Dalenc, Suzette Delaloge,[...]. Br J Cancer 2019
43
18

Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?
Adam S Komorowski, Ellen Warner, Helen J MacKay, Arjun Sahgal, Kathleen I Pritchard, Katarzyna J Jerzak. Clin Breast Cancer 2020
23
18

Metastatic behavior of breast cancer subtypes.
Hagen Kennecke, Rinat Yerushalmi, Ryan Woods, Maggie Chon U Cheang, David Voduc, Caroline H Speers, Torsten O Nielsen, Karen Gelmon. J Clin Oncol 2010
18

External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
Gaia Griguolo, William Jacot, Eva Kantelhardt, Maria Vittoria Dieci, Céline Bourgier, Christoph Thomssen, Caroline Bailleux, Federica Miglietta, Antoine-Laurent Braccini, PierFranco Conte,[...]. Breast 2018
20
18

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Paul D Brown, Karla V Ballman, Jane H Cerhan, S Keith Anderson, Xiomara W Carrero, Anthony C Whitton, Jeffrey Greenspoon, Ian F Parney, Nadia N I Laack, Jonathan B Ashman,[...]. Lancet Oncol 2017
495
18

The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis.
Markus Kuksis, Yizhuo Gao, William Tran, Christianne Hoey, Alex Kiss, Adam S Komorowski, Aman J Dhaliwal, Arjun Sahgal, Sunit Das, Kelvin K Chan,[...]. Neuro Oncol 2021
17
18

Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.
May N Tsao, Wei Xu, Rebecca Ks Wong, Nancy Lloyd, Normand Laperriere, Arjun Sahgal, Eileen Rakovitch, Edward Chow. Cochrane Database Syst Rev 2018
78
18

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
Paul D Brown, Vinai Gondi, Stephanie Pugh, Wolfgang A Tome, Jeffrey S Wefel, Terri S Armstrong, Joseph A Bovi, Cliff Robinson, Andre Konski, Deepak Khuntia,[...]. J Clin Oncol 2020
236
18

Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies.
Alejandro Garcia-Alvarez, Andri Papakonstantinou, Mafalda Oliveira. Cancers (Basel) 2021
11
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.